Natural immune booster market to reach $23.2 billion by 2030 at 8.4% cagr, driven by growing awareness of health and wellness and preventive healthcare trends.
Read MoreMessenger ribonucleic acid quality monitoring market to reach $2.49 billion by 2030 at 11.0% CAGR, driven by increasing demand for personalized medicines.
Read MoreNatural baby body massage oil market to reach $2.21 billion by 2030 at 7.3% cagr, driven by expanding e-commerce and rising demand for organic baby care products.
Read MoreNasal sprays market to reach $55.37 billion by 2030 at 10.4% cagr, driven by increasing prevalence of respiratory disorders and preference for localized treatments.
Read MoreMessenger ribonucleic acid (mrna) synthesis raw materials market to reach $3.65 billion by 2030 at 4.0% CAGR, driven by growing incidence of cancer and chronic disorders.
Read MoreNasal corticosteroids market to reach $9.87 billion by 2030 at 8.0% cagr, driven by increasing prevalence of respiratory diseases and allergic conditions.
Read MoreMessenger ribonucleic acid (mrna) synthesis and manufacturing market to reach $9.22 billion by 2030 at 12.3% CAGR, driven by increasing prevalence of infectious diseases.
Read MoreNarcotic drugs market to reach $18.79 billion by 2030 at 5.2% cagr, driven by rising incidence of chronic diseases requiring long-term pain management.
Read MoreMessenger ribonucleic acid (mrna) capping enzyme market to reach $1.97 billion by 2030 at 14.1% CAGR, driven by growing adoption of personalized medicine.
Read MoreNanotechnology based medical devices market to reach $23.24 billion by 2030 at 36.9% cagr, driven by increasing adoption of personalized medicine and precision healthcare tools.
Read More